Case Report

Anaphylactic Shock: The Great Mimic

Authors: Patrick F. K. Yong, MBChB, MRCP, Jonathan Birns, BSc, MRCP, Mohammad A. A. Ibrahim, PhD, MRCPath

Abstract

Anaphylaxis, acute coronary syndrome and pulmonary embolism are conditions commonly seen in the acute medical setting which can be difficult to diagnose. Delay in establishing the correct diagnosis can result in either delayed or inappropriate treatment, and subsequent morbidity and mortality. The cases we present highlight the necessity of good clinical assessment when evaluating such patients.


Key Point


* Anaphylaxis can mimic other medical emergencies and should be considered in the differential diagnosis.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Moneret-Vautrin DA, Morisset M, Flabbee J, et al. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005;60:443–451.
 
2. Lieberman PL. Specific and idiopathic anaphylaxis: pathophysiology and treatment. In: Bierman CW, Pearlman DS, Shapiro GG, et al, eds. Allergy, Asthma and Immunology From Infancy to Adulthood.Third edition. Philadelphia, WB Saunders, 1996, pp 297–319.
 
3. Fisher MM. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care 1986;14:17–21.
 
4. Wasserman S. The heart in anaphylaxis. J Allergy Clin Immunol 1986;77:663–666.
 
5. Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 2005;5:359–364.
 
6. Schwartz LB, Metcalf DD, Miller JS, et al. Tryptase levels as an indicator of mast cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987;316:1622–1626.
 
7. LaRoche D, Vergnaud M, Sillard B, et al. Biochemical markers of anaphylactoid reactions to drugs: comparison of plasma histamine and tryptase. Anesthesiology 1991;75:945–949.
 
8. van der Linden PW, Hack CE, Struyvenberg A, et al. Controlled insect-sting challenge in 55 patients: correlation between activation of plasminogen and the development of anaphylactic shock. Blood 1993;82: 1740–1748.